NO831950L - Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling - Google Patents

Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling

Info

Publication number
NO831950L
NO831950L NO831950A NO831950A NO831950L NO 831950 L NO831950 L NO 831950L NO 831950 A NO831950 A NO 831950A NO 831950 A NO831950 A NO 831950A NO 831950 L NO831950 L NO 831950L
Authority
NO
Norway
Prior art keywords
compounds
hydrogen
formula
benzyl
cyanidan
Prior art date
Application number
NO831950A
Other languages
English (en)
Norwegian (no)
Inventor
Marc Ernest Ballenegger
Christian Gerard Rimbault
Alban Imre Albert
Andre Jean Weith
Pierre Courbat
Robert Graham Tyson
Derek Reginald Palmer
David George Thompson
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of NO831950L publication Critical patent/NO831950L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
NO831950A 1982-06-01 1983-05-31 Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling NO831950L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8215867 1982-06-01

Publications (1)

Publication Number Publication Date
NO831950L true NO831950L (no) 1983-12-02

Family

ID=10530750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831950A NO831950L (no) 1982-06-01 1983-05-31 Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling

Country Status (19)

Country Link
US (1) US4644011A (es)
EP (1) EP0096007B1 (es)
JP (1) JPS58219177A (es)
KR (1) KR840005124A (es)
AT (1) ATE28641T1 (es)
AU (1) AU568301B2 (es)
CA (1) CA1234103A (es)
DD (1) DD210687A5 (es)
DE (1) DE3372764D1 (es)
DK (1) DK245283A (es)
ES (2) ES8507533A1 (es)
FI (1) FI831926L (es)
GB (1) GB2122608B (es)
GR (1) GR78346B (es)
IL (1) IL68832A (es)
NO (1) NO831950L (es)
NZ (1) NZ204422A (es)
PT (1) PT76782B (es)
ZA (1) ZA833908B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141745A (en) * 1986-03-27 1992-08-25 The Lubrizol Corporation Nodulation inducing factors
US4743694A (en) * 1986-04-11 1988-05-10 Mercek & Co., Inc. Diastereocontrolled synthesis of 2-amino alcohols
EP0270690B1 (en) * 1986-06-21 1991-05-15 Dainippon Ink And Chemicals, Inc. Drug for treatment and prophylaxis of kidney and liver diseases
US6207842B1 (en) 1997-10-09 2001-03-27 Mars Incorporated Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
US6156912A (en) * 1999-04-09 2000-12-05 Mars, Incorporated 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation
US7015338B1 (en) 1999-04-15 2006-03-21 Mars Incorporated Synthetic methods for preparing procyanidin oligomers
NL1016815C2 (nl) * 1999-12-15 2002-05-14 Ciba Sc Holding Ag Oximester-fotoinitiatoren.
US6476241B1 (en) * 2000-09-05 2002-11-05 Mars Incorporated Synthesis of 4α-arylepicatechins
US7067679B2 (en) 2002-10-02 2006-06-27 Mars, Inc. Synthesis of dimeric, trimeric, tetrameric pentameric, and higher oligomeric epicatechin-derived procyanidins having 4,8-interflavan linkages and their use to inhibit cancer cell growth through cell cycle arrest
US20070004796A1 (en) * 2005-06-29 2007-01-04 Romanczyk Leo Jr Processes for the preparation of protected-(+)-catechin and (-)-epicatechin monomers, for coupling the protected monomers with an activated, protected epicatechin monomer, and for the preparation of epicatechin-(4B,8)-epicatechin or -catechin dimers and their digallates
WO2011128714A1 (en) * 2010-04-12 2011-10-20 Berkem S.A. Stabilised polyphenol derivatives, process for their manufacture, and uses thereof
JP5890846B2 (ja) * 2011-01-27 2016-03-22 スファエラ ファーマ ピーティーイー リミテッド ポリフェノールの新規合成方法
CN106518802B (zh) * 2016-11-17 2018-11-09 山东铂源药业有限公司 一种2-(3-醛基-4-羟基苯基)-4-甲基噻唑-5-甲酸乙酯的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575004A (en) * 1976-03-23 1980-09-17 Iverni Della Beffa Spa Pharmacologically active polyphenolic substances
US4255336A (en) * 1977-11-25 1981-03-10 Ciba-Geigy Corporation Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01
EP0037800B1 (de) * 1980-04-03 1987-08-12 Zyma SA Verwendung von O-substituierten Derivaten von (+)-Cyanidanol-3 als Verbindungen mit immunomodulatorischen Eigenschaften

Also Published As

Publication number Publication date
JPS58219177A (ja) 1983-12-20
EP0096007B1 (en) 1987-07-29
ES522814A0 (es) 1985-09-16
PT76782B (en) 1986-05-20
AU1525583A (en) 1983-12-08
FI831926A0 (fi) 1983-05-30
KR840005124A (ko) 1984-11-03
NZ204422A (en) 1986-09-10
IL68832A (en) 1988-06-30
CA1234103A (en) 1988-03-15
DD210687A5 (de) 1984-06-20
ES8704919A1 (es) 1987-04-16
AU568301B2 (en) 1987-12-24
PT76782A (en) 1983-06-01
ES536423A0 (es) 1987-04-16
DE3372764D1 (en) 1987-09-03
ATE28641T1 (de) 1987-08-15
GR78346B (es) 1984-09-26
EP0096007A2 (en) 1983-12-07
EP0096007A3 (en) 1984-01-04
DK245283A (da) 1983-12-02
FI831926A7 (fi) 1983-12-02
ES8507533A1 (es) 1985-09-16
IL68832A0 (en) 1983-09-30
US4644011A (en) 1987-02-17
GB2122608B (en) 1985-10-02
ZA833908B (en) 1984-01-25
DK245283D0 (da) 1983-05-31
FI831926L (fi) 1983-12-02
GB2122608A (en) 1984-01-18
GB8312765D0 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
EP2844637B1 (en) Substituted 3-haloallylamine inhibitors of ssao and uses thereof
EP0373998B1 (fr) Ethers d'oxime de propénone, procédé pour leur préparation et compositions pharmaceutiques les contenant
EA016360B1 (ru) Ингибиторы 11-бета-гидроксистероид дегидрогеназы 1, фармацевтическая композиция на их основе и их применение
NO172343B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater
UA43853C2 (uk) Арилалкілпіридазинони, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
JPS607997B2 (ja) ヒダントイン誘導体治療剤
EP0096007B1 (en) Pharmaceutical preparations containing (+)-cyanidan-3-ol derivatives, the use thereof, novel substituted (+)-cyanidan-3-ol derivatives, and processes for producing them
EP0997458A1 (en) Novel tricyclic compounds having saturated rings and medicinal compositions containing the same
EP0125195B1 (fr) Nouveaux acides flavonecarboxyliques-4', leur méthode de préparation et leur application thérapeutique
NO174892B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser
WO1991016303A1 (en) Cyclic hydroxamic acids and their use
NO148673B (no) Analogifremgangsmaate ved fremstilling av farmakologisk virksomme tiofenderivater
NO169648B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
Bender et al. Synthesis and biological properties of some novel heterocyclic homoprostanoids
EP1098873B1 (en) Alpha-(2-hydroxyphenyl)nitrone compounds, pharmaceutical compositons containing the same and their use for treating inflammation
SU1452481A3 (ru) Способ получени гетероциклических соединений
EP0032856A1 (fr) Nouveaux dérivés de dihydro-2,3-imidazo(1,2-b)pyridazines, leur procédé de préparation et leur application en thérapeutique
EP0096008B1 (en) (+)-cyanidan-3-ol derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter
JP2002529409A (ja) グルコース及び脂質低下化合物類
GB2145719A (en) Flavene and thioflavene derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter
US3972883A (en) 1,6-Dimethyl-8β-[2' or 3'-pyrroyloxyethyl or substituted pyrroyloxyethyl]-10α-methoxyergolene compounds
WO2025255550A1 (en) Flavone therapeutics
BE884145R (fr) Composes indoliques nouveaux
BE899255R (fr) Betta-oxo-alpha-carbanoyl-pyrrolpropionitriles, procede pour leur preparation, preparations pharmaceutiques contenant ces composes, ainsi que leur application therapeutique.
NO783529L (no) Nye derivater av tiazolin.